Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
AZAnUQj8XSakTkLC
